J. Hoorntje

发表

Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial

S. Cook, M. Meuwissen, C. von Birgelen, 2018, British Medical Journal.

Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions

P. Harst, J. Wykrzykowska, P. van der Harst, 2017, Netherlands Heart Journal.

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

Fach, Thilo, D. DeMets, 1999, The Lancet.

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.

J. Reiber, H. Suryapranata, M. de Boer, 1993, The New England journal of medicine.

Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study.

William Wijns, Ganesh Manoharan, Eric Boersma, 2007, Journal of the American College of Cardiology.

The relation between the atrial blood supply and the complexity of acute atrial fibrillation☆

H. Crijns, U. Schotten, J. Maessen, 2021, International journal of cardiology. Heart & vasculature.

The prognostic importance of heart failure and age in patients treated with primary angioplasty

H. Suryapranata, J. Henriques, J. Hoorntje, 2003, European journal of heart failure.

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)

Fach, Thilo, D. DeMets, 1999, The Lancet.

Patency and Reinfarction in Late-Entry Myocardial Infarct Patients Treated with Reperfusion Therapy

H. Suryapranata, A. V. Van't Hof, M. de Boer, 1997, Angiology.

Prognostic importance of left ventricular function after angioplasty or thrombolysis for acute myocardial infarction : Long-term results of the zwolle trial

J. Ottervanger, H. Suryapranata, M. de Boer, 2001 .

Impact of ST-segment depression resolution on mortality after successful mechanical reperfusion in patients with ST-segment elevation acute myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

Effect of coronary occlusion site on angiographic and clinical outcome in acute myocardial infarction patients treated with early coronary intervention.

J. Ottervanger, H. Suryapranata, G. Borm, 2006, The American journal of cardiology.

Relation of interhospital delay and mortality in patients with ST-segment elevation myocardial infarction transferred for primary coronary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

Impact of ischemic time on post-infarction left ventricular function in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

J. Ottervanger, H. Suryapranata, M. de Boer, 2013, International journal of cardiology.

Limitation of Infarct Size and Preservation of Left Ventricular Function After Primary Coronary Angioplast Compared With Intravenous Streptokinase in Acute Myocardial Infarction

H. Suryapranata, M. J. van den Brand, M. de Boer, 1994, Circulation.

Suboptimal anticoagulation with pre-hospital heparin in ST-elevation myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, Thrombosis and Haemostasis.

Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2001, Heart.

Long term outcome and coste V ectiveness of stenting versus balloon angioplasty for acute myocardial infarction

J. Ottervanger, H. Suryapranata, F. Zijlstra, 2001 .

Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis: A Randomized Trial

William Wijns, Javier Escaned, Ebo D. de Muinck, 2001, Circulation.

Ventricular fibrillation in acute myocardial infarction before and during primary PCI.

J. Ottervanger, H. Suryapranata, M. de Boer, 2005, International journal of cardiology.

Impact of routine stenting on myocardial perfusion and the extent of myocardial necrosis in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, American heart journal.

Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, European heart journal.

Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2002, European heart journal.

Unwarranted variation of coronary stent choice in The Netherlands

J. Hoorntje, S. Bekkers, 2016, Netherlands Heart Journal.

The effect of thrombus aspiration during primary percutaneous coronary intervention on clinical outcome in daily clinical practice

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2013, Thrombosis and Haemostasis.

Randomized Trial of a GPIIb/IIIa Platelet Receptor Blocker in Refractory Unstable Angina

H. Weisman, M. Simoons, P. D. de Feyter, 1994, Circulation.

Chapter 4 Troponin T elevation and prognosis after multivessel compared to single vessel elective percutaneous coronary intervention

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2008 .

Troponin T elevation and prognosis after multivessel compared with single-vessel elective percutaneous coronary intervention

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Statin therapy and mortality in patients

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2008 .

Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, Atherosclerosis.

Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 1999, The New England journal of medicine.

Predictors and importance of prolonged hospital stay after primary PCI for ST elevation myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, Coronary artery disease.

Primary percutaneous coronary intervention for ST-elevation myocardial infarction: from clinical trial to clinical practice.

J. Ottervanger, H. Suryapranata, M. de Boer, 2009, International journal of cardiology.

Impact of beta-blocker therapy at discharge on long-term mortality after primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

J. Ottervanger, H. Suryapranata, G. De Luca, 2004, American heart journal.

Angiographic determinants of infarct size after successful percutaneous intervention for acute ST-elevation myocardial infarction: the impact of distal embolisation.

J. Ottervanger, H. Suryapranata, M. de Boer, 2002, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction

H. Suryapranata, A. V. Van't Hof, M. de Boer, 1997, Heart.

No mortality benefit of primary angioplasty over thrombolytic therapy in patients with nonanterior myocardial infarction at long-term follow-up: Results of the zwolle trial

J. Henriques, J. Hoorntje, F. Zijlstra, 2003 .

Impact of out-of-hospital cardiac arrest due to ventricular fibrillation in patients with ST-elevation myocardial infarction admitted for primary percutaneous coronary intervention: Impact of ventricular fibrillation in STEMI patients

J. Ottervanger, A. Elvan, F. Demirel, 2015, European heart journal. Acute cardiovascular care.

Circumflex artery related myocardial infarction: less reperfusion therapy and large infarct size.

J. Ottervanger, H. Suryapranata, V. Roolvink, 2013, International journal of cardiology.

Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMI.

J. Ottervanger, M. de Boer, F. Zijlstra, 2007, The Netherlands journal of medicine.

Are patients with non-ST elevation myocardial infarction undertreated?

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2007, BMC cardiovascular disorders.

External validity of ST elevation myocardial infarction trials: The Zwolle studies

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes.

J. Ottervanger, J. Hoorntje, F. Zijlstra, 2006, QJM : monthly journal of the Association of Physicians.

Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention.

J. Ottervanger, H. Suryapranata, G. Borm, 2006, American heart journal.

Clinical and angiographic predictors of outcome after primary angioplasty

H. Suryapranata, M. de Boer, F. Zijlstra, 2007 .

A comparison of dual vs. triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: results of the ELISA-2 trial.

J. Ottervanger, H. Suryapranata, M. de Boer, 2005, European heart journal.

A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes.

H. Suryapranata, M. de Boer, J. Hoorntje, 2003, European heart journal.

Acute blindness as the presenting symptom of ST segment elevation myocardial infarction.

J. Ottervanger, J. Henriques, J. Hoorntje, 2004, International journal of cardiology.

Prognostic importance of troponin T and creatine kinase after elective angioplasty.

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, International journal of cardiology.

Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2008, American heart journal.

Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?

J. Ottervanger, H. Suryapranata, M. de Boer, 2010 .

Mortality in patients with left ventricular ejection fraction

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, The American journal of cardiology.

Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2007, International journal of cardiology.

Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, Journal of Thrombosis and Thrombolysis.

Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Limitation of myocardial infarct size after primary angioplasty: is a higher patency the only mechanism?

J. Ottervanger, H. Suryapranata, M. de Boer, 1999, American heart journal.

Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2005, Journal of the American College of Cardiology.

Long-term, cause-specific mortality after myocardial infarction in diabetes.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, European heart journal.

Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 1994, Journal of the American College of Cardiology.

The influence of time to treatment on clinical outcome in patients with acute myocardial infarction treated with primary angioplasty

H. Suryapranata, F. Zijlstra, J. Hoorntje, 1997 .

Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction.

H. Suryapranata, M. de Boer, F. Verheugt, 2002, Journal of the American College of Cardiology.

High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial.

J. Ottervanger, H. Suryapranata, M. de Boer, 2000, Journal of the American College of Cardiology.

Routine stenting for acute myocardial infarction: a randomized trial in unselected patients

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2004 .

Cardiac ANCA-associated vasculitis mimicking an acute coronary syndrome.

M. Metra, J. Hoorntje, R. Lorusso, 2016, International journal of cardiology.

Primary angioplasty: preprocedural pharmacological therapy.

H. Suryapranata, M. de Boer, F. Zijlstra, 2006, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Age-dependent differences in diabetes and acute hyperglycemia between men and women with ST-elevation myocardial infarction: a cohort study

J. Ottervanger, H. Suryapranata, A. Maas, 2013, Diabetology & Metabolic Syndrome.

Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty.

H. Suryapranata, M. de Boer, F. Zijlstra, 1998, Journal of the American College of Cardiology.

Clinical characteristics and outcome of patients with acute myocardial infarction and preinfarction angina.

H. Suryapranata, M. de Boer, F. Zijlstra, 2001, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Thrombolysis or primary angioplasty for acute myocardial infarction?

M. de Boer, F. Zijlstra, J. Hoorntje, 1997, The New England journal of medicine.

Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, Thrombosis and Haemostasis.

Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance

J. Ottervanger, H. Suryapranata, A. Elvan, 2012, Netherlands Heart Journal.

Current MitraClip experience, safety and feasibility in the Netherlands

M. Voskuil, I. Kardys, J. Hoorntje, 2017, Netherlands Heart Journal.

The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616]

M. Nijsten, J. Ottervanger, H. Suryapranata, 2005, BMC medicine.

randomized trial for acute myocardial infarction: The glucose-insulin-potassium study: a Glucose-insulin-potassium infusion inpatients treated with primary angioplasty

H. Suryapranata, J. Hoorntje, F. Zijlstra, 2011 .

The predictive value of cumulative lactate dehydrogenase release within the first 72 h of acute myocardial infarction in patients treated with primary angioplasty

H. Suryapranata, M. de Boer, J. Hoorntje, 2004, Annals of clinical biochemistry.

Instantaneous wave-free ratio and fractional flow reserve in clinical practice

J. Hoorntje, R. Pisters, L. Veenstra, 2018, Netherlands Heart Journal.

Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, Heart.

Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: An angiographic risk score for use in the catheterization laboratory

J. Ottervanger, H. Suryapranata, M. de Boer, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Prehospital triage for angiography-guided therapy for acute myocardial infarction.

H. Suryapranata, M. de Boer, J. Hoorntje, 2004, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Predictors of early ventricular fibrillation before reperfusion therapy for acute ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

NT‐proBNP: a marker for successful myocardial reperfusion in AMI patients treated with primary percutaneous coronary intervention

J. Henriques, J. Hoorntje, R. Slingerland, 2004, European journal of heart failure.

Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction.

H. Suryapranata, M. de Boer, F. Zijlstra, 1998, European heart journal.

Incidence and predictors of restenosis after successful primary coronary angioplasty for acute myocardial infarction: the importance of age and procedural result.

H. Suryapranata, M. de Boer, J. Hoorntje, 1998, American heart journal.

Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction.

H. Suryapranata, M. Simoons, M. de Boer, 1996, European heart journal.

A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction.

H. Suryapranata, M. de Boer, F. Zijlstra, 1995, The American journal of cardiology.

Primary angioplasty compared with thrombolysis in acute myocardial infarction in diabetic patients.

J. Ottervanger, H. Suryapranata, M. de Boer, 1999, Diabetes care.

Poor outcome after recurrent acute myocardial infarction: a plea for optimal secondary prevention.

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, International journal of cardiology.

Marked reduction of early stent thrombosis with pre‐hospital initiation of high‐dose Tirofiban in ST‐segment elevation myocardial infarction

M. de Boer, C. Hamm, J. T. ten Berg, 2009, Journal of thrombosis and haemostasis : JTH.

Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, Heart.

A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction.

H. Suryapranata, M. de Boer, F. Zijlstra, 1999, European heart journal.

Clinical and quantitative angiographic results of a randomized trial comparing direct coronary angioplasty with intravenous streptokinase in acute myocardial infarction

J. Reiber, H. Suryapranata, J. Hoorntje, 1994 .

Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Impaired Myocardial Perfusion Is a Major Explanation of the Poor Outcome Observed in Patients Undergoing Primary Angioplasty for ST-Segment–Elevation Myocardial Infarction and Signs of Heart Failure

J. Ottervanger, H. Suryapranata, G. De Luca, 2004, Circulation.

Predictors of mortality and risk stratification in primary angioplasty Part 3

H. Suryapranata, J. Hoorntje, F. Zijlstra, 2004 .

Angiographic determination of myocardial reperfusion by primary coronary angioplasty for acute myocardial infarction.

H. Suryapranata, M. de Boer, F. Zijlstra, 2002, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial

J. Ottervanger, J. Hoorntje, J. Dambrink, 2012, Netherlands Heart Journal.

Circumflex artery-related acute myocardial infarction: limited ECG abnormalities but poor outcome

J. Ottervanger, H. Suryapranata, F. Zijlstra, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

P Myocardial Infarction yperglycemia Is an Important redictor of Impaired Coronary low Before Reperfusion Therapy in T-Segment Elevation Myocardial Infarction

J. Ottervanger, J. Hoorntje, F. Zijlstra, 2016 .

Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction.

J. Reiber, H. Suryapranata, M. de Boer, 1995, European heart journal.

Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2009, Coronary artery disease.

Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis

E. Boersma, W. Wijns, J. Hoorntje, 2007 .

Costs of stenting for acute myocardial infarction

H. Suryapranata, J. Hoorntje, F. Zijlstra, 1998, The Lancet.

Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, Journal of the American College of Cardiology.

A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI

J. Ottervanger, H. Suryapranata, J. M. Berg, 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count.

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, The Journal of laboratory and clinical medicine.

Multivessel revascularisation versus infarct-related artery only revascularisation during the index primary PCI in STEMI patients with multivessel disease: a meta-analysis

J. Hoorntje, V. V. van Ommen, V. Ommen, 2015, Netherlands Heart Journal.

chieved Platelet Aggregation Inhibition fter Different Antiplatelet Regimens uring Percutaneous Coronary Intervention or ST-Segment Elevation Myocardial Infarction

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2016 .

Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome.

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, American heart journal.

Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Prediction of success and major complications during elective coronary angioplasty.

H. Suryapranata, M. de Boer, J. Hoorntje, 2001, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Severe spontaneous coronary artery dissection in a 42-year-old male: a treatment strategy challenge.

J. Hoorntje, J. Merken, S. Altintas, 2014, International journal of cardiology.

Treatment assignment in young women with spontaneous coronary artery dissection.

J. Ottervanger, H. Suryapranata, A. Maas, 2014, International journal of cardiology.

Final benefit of primary percutaneous coronary intervention for ST-elevation myocardial infarction in older patients: long-term results of a randomised trial

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2022, Netherlands Heart Journal.

Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2010 .

Impact of routine stenting on clinical outcome in diabetic patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, Diabetes care.

Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2007, International journal of cardiology.

Postprocedural single-lead ST-segment deviation and long-term mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty

J. Ottervanger, H. Suryapranata, G. De Luca, 2007, Heart.

Closure device or manual compression in patients undergoing percutaneous coronary intervention: a randomized comparison.

J. Ottervanger, H. Suryapranata, A. V. Van't Hof, 2010, The Journal of invasive cardiology.

Primary coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: differences in outcome during a mean follow‐up of 18 months

J. Ottervanger, H. Suryapranata, M. de Boer, 1994, Coronary artery disease.

Angiographic and clinical one‐year follow‐up of the Cordis tantalum coil stent in a multicenter international study demonstrating improved restenosis rates when compared to pooled PTCA and BENESTENT‐I data: The European Antiplatelet Stent Investigation (EASI)

P. Serruys, A. Gershlick, W. Wijns, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Routine stenting vs. balloon angioplasty in ST-segment elevation myocardial infarction due to proximal left anterior descending coronary artery occlusion

J. Ottervanger, H. Suryapranata, G. De Luca, 2009, Journal of cardiovascular medicine.

Comparison between stenting and balloon angioplasty in patients undergoing primary angioplasty of small coronary vessels.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, American heart journal.

Relationship between time-to-reperfusion and 30-day mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty

H. Suryapranata, J. Hoorntje, F. Zijlstra, 2003 .

Impaired platelet inhibitory effect of a single dose of acetylsalicylic acid in patients with unstable coronary artery syndrome in comparison with healthy volunteers.

W. van Oeveren, J. Hoorntje, K. Miedema, 2004, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Bleeding after stenting: statistics in daily practice.

J. Hoorntje, 2018, International journal of cardiology.

Pre-treatment with clopidogrel and postprocedure troponin elevation after elective percutaneous coronary intervention

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, Thrombosis and Haemostasis.

Comparison of rapamycin- and paclitaxel-eluting stents in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2009, The American journal of cardiology.

Acute Anterior Wall Myocardial Infarction during Pregnancy in a 36-Year Old Patient

J. Hoorntje, L. Veenstra, T. Lenderink, 2015 .

The importance of patency of the infarct-related artery in treatment of patients with acute myocardial infarction.

H. Suryapranata, M. de Boer, F. Zijlstra, 2003, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, American heart journal.

Heritability in a SCN5A-mutation founder population with increased female susceptibility to non-nocturnal ventricular tachyarrhythmia and sudden cardiac death.

A. Isaacs, P. Volders, J. Hoorntje, 2017, Heart rhythm.

Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, Thrombosis and Haemostasis.

Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction.

H. Suryapranata, M. de Boer, J. Hoorntje, 1998, Circulation.

Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2004, European heart journal.

Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.

H. Suryapranata, G. De Luca, M. de Boer, 2003, Journal of the American College of Cardiology.

Contemporary use of arterial and venous conduits in coronary artery bypass grafting: anatomical, functional and clinical aspects

J. Maessen, J. Hoorntje, R. Lorusso, 2016, Netherlands Heart Journal.

Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.

H. Suryapranata, M. de Boer, F. Zijlstra, 1998, Circulation.

Change of white blood cell count more prognostic important than baseline values after primary percutaneous coronary intervention for ST elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2008, Thrombosis research.

Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia

J. Ottervanger, H. Suryapranata, F. Zijlstra, 2005, Journal of internal medicine.

Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2009, Coronary artery disease.

Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, American heart journal.

Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial.

H. Suryapranata, M. de Boer, J. Hoorntje, 2004, European heart journal.

Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, American heart journal.

Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy.

J. Ottervanger, H. Suryapranata, M. de Boer, 2002, Journal of the American College of Cardiology.

Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.

Felix Zijlstra, Jan-Henk E Dambrink, H. Suryapranata, 2003, Journal of the American College of Cardiology.

Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age

J. Ottervanger, H. Suryapranata, A. Maas, 2013, European heart journal. Acute cardiovascular care.

Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade

Felix Zijlstra, Jan-Henk E Dambrink, H. Suryapranata, 2003, Circulation.

Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction.

H. Suryapranata, M. de Boer, J. Hoorntje, 1997, Journal of the American College of Cardiology.

Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2001, European heart journal.

Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2008, The American journal of cardiology.

Long-term comparison of balloon angioplasty with provisional stenting versus routine stenting in patients with non-ST-elevation acute coronary syndrome

H. Suryapranata, J. Hoorntje, D. Schellings, 2010, Netherlands Heart Journal.

Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction.

J. Ottervanger, H. Suryapranata, G. De Luca, 2006, American heart journal.

Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty.

H. Suryapranata, G. De Luca, M. de Boer, 2004, Journal of the American College of Cardiology.

Outcome in patients treated with primary angioplasty for acute myocardial infarction due to left main coronary artery occlusion.

H. Suryapranata, G. De Luca, M. de Boer, 2003, American Journal of Cardiology.

Randomised comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction

H. Suryapranata, J. Hoorntje, F. Zijlstra, 1998 .

Impact of vessel size on distal embolization, myocardial perfusion and clinical outcome in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2009, Journal of Thrombosis and Thrombolysis.

Primary percutaneous coronary intervention versus thrombolytic treatment: long term follow up according to infarct location

J. Ottervanger, H. Suryapranata, M. de Boer, 2005, Heart.

Prognostic implications of myocardial injury around percutaneous coronary interventions

J. Ottervanger, H. Suryapranata, M. de Boer, 2008 .

Angiography guided therapy in an all comer acute coronary syndrome patient population.

J. Ottervanger, H. Suryapranata, M. de Boer, 2013, International journal of cardiology.

Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction

J. Ottervanger, H. Suryapranata, R. Hermanides, 2016, Open Heart.

Early Discharge After Primary Percutaneous Coronary Intervention: The Added Value of N‐Terminal Pro–Brain Natriuretic Peptide to the Zwolle Risk Score

H. Suryapranata, E. Giannitsis, C. Hamm, 2014, Journal of the American Heart Association.

Crossing failure in PTCA: mind the deflated balloon profile!

M. de Boer, F. Zijlstra, J. Hoorntje, 1991, Catheterization and cardiovascular diagnosis.

Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty: Implications for Early Discharge

Felix Zijlstra, J. Ottervanger, H. Suryapranata, 2004, Circulation.

Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty.

J. Ottervanger, H. Suryapranata, G. De Luca, 2005, The American journal of cardiology.

A quantitative analysis of the benefits of pre-hospital infarct angioplasty triage on outcome in patients undergoing primary angioplasty for acute myocardial infarction

H. Suryapranata, J. Hoorntje, F. Zijlstra, 2005 .

Prehospital triage in the ambulance reduces infarct size and improves clinical outcome.

J. Ottervanger, H. Suryapranata, M. de Boer, 2011, American heart journal.

Cardiac shockwave therapy in patients with chronic refractory angina pectoris

J. Hoorntje, J. Waltenberger, S. Schalla, 2016, Netherlands Heart Journal.

Flow and ortality in Patients With Acute yocardial Infarction Treated by Primary Angioplasty

H. Suryapranata, J. Hoorntje, F. Zijlstra, 2016 .

Comparison of radionuclide angiography with three echocardiographic parameters of left ventricular function in patients after myocardial infarction

J. Hoorntje, S. Reiffers, J. Gerritsen, 1998, The International Journal of Cardiac Imaging.

Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stenting

J. Ottervanger, H. Suryapranata, G. De Luca, 2004, Thrombosis and Haemostasis.

Dysglycemia in suspected acute coronary syndromes.

J. Ottervanger, J. Hoorntje, F. Zijlstra, 2005, European journal of internal medicine.

Preoperative planning with three-dimensional reconstruction of patient's anatomy, rapid prototyping and simulation for endoscopic mitral valve repair.

J. Maessen, J. Hoorntje, E. Cheriex, 2016, Interactive cardiovascular and thoracic surgery.

Old Age and Outcome After Primary Angioplasty for Acute Myocardial Infarction

J. Ottervanger, H. Suryapranata, M. de Boer, 2010, Journal of the American Geriatrics Society.

How to change an over-the-wire PTCA balloon over a normal short guidewire.

J. Hoorntje, 1989, Catheterization and cardiovascular diagnosis.

Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction.

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2000, European heart journal.

Are patients with non-ST elevation myocardial infarction undertreated?

J. Ottervanger, H. Suryapranata, M. de Boer, 2007, BMC cardiovascular disorders.

Prognostic implications of myocardial injury around percutaneous coronary interventions

J. Ottervanger, H. Suryapranata, H. Bilo, 2008 .

Prognostic value of admission glucose in non-diabetic patients with myocardial infarction.

J. Ottervanger, H. Suryapranata, M. de Boer, 2004, American heart journal.

Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.

H. Suryapranata, M. de Boer, J. Hoorntje, 2003, Journal of the American College of Cardiology.

Long term outcome and cost-e V ectiveness of stenting versus balloon angioplasty for acute myocardial infarction

J. Ottervanger, J. Hoorntje, F. Zijlstra, 2001 .

Coronary artery bypass grafting early after acute myocardial infarction in patients initially treated with thrombolytic therapy or coronary angioplasty

H. Suryapranata, M. de Boer, J. Hoorntje, 1994, Coronary artery disease.

Prognostic implications of myocardial injury around percutaneous coronary interventions

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2008 .

A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI

J. Ottervanger, H. Suryapranata, J. Hoorntje, 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

The predictive value of cumulative lactate dehydrogenase release within the first 72 h of acute myocardial infarction in patients treated with primary angioplasty

H. Suryapranata, M. de Boer, J. Hoorntje, 2004, Annals of clinical biochemistry.

Effect of coronary occlusion site on angiographic and clinical outcome in acute myocardial infarction patients treated with early coronary intervention.

J. Ottervanger, H. Suryapranata, M. de Boer, 2006, The American journal of cardiology.

The ESSEX (European Scimed Stent Experience) study

P. Serruys, W. J. van der Giessen, M. Sabaté, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.